Cita APA (7a ed.)

MC, Á., S, O., G, C., M, C., J, O., P, S., . . . E, M. (2021). Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press.

Cita Chicago Style (17a ed.)

MC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.

Cita MLA (8a ed.)

MC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.